Stock BDRX BIODEXA PHARMACEUTICALS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Biodexa Pharmaceuticals Plc

Equities

BDRX

US59564R7089

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-06-06 pm EDT 		5-day change 1st Jan Change
0.9999 USD +1.00% Intraday chart for Biodexa Pharmaceuticals Plc +2.01% -62.69%
Jun. 05 European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading MT
Jun. 04 European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading MT

Evolution of the average Target Price on Biodexa Pharmaceuticals Plc

Price target over the last 5 years

History of analyst recommendation changes

215fbf1a20dca6112f8a5.lJRMH9mCAHoHlF5k5OsoixIvoR1mXIHcyMVBwZ7ngJU.0csAT5fBNDwz3TszpsZEzkYc5y4zMO7tqq4Xudar1_r1oh0okOE1Q0TyCw~9ebb1183c7998dc59a1294972bf94746

Analyst Recommendations on Biodexa Pharmaceuticals Plc

Ladenburg Thalmann Starts Biodexa Pharmaceuticals With Buy Rating, $8 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.782 GBP
Average target price
6.257 GBP
Spread / Average Target
+700.10%
High Price Target
6.257 GBP
Spread / Highest target
+700.10%
Low Price Target
6.257 GBP
Spread / Lowest Target
+700.10%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Biodexa Pharmaceuticals Plc

Ladenburg Thalmann

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BDRX Stock
  4. Consensus Biodexa Pharmaceuticals Plc